Brief: Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
02/12/2024 13:21
Dec 2 (Reuters) - Allurion Technologies Inc ALUR.N :
* ALLURION ANNOUNCES NYSE ACCEPTANCE OF PLAN TO REGAIN
LISTING
COMPLIANCE
* ALLURION TECHNOLOGIES INC - EXPECTS TO REGAIN COMPLIANCE
BY
MARCH 1, 2026
Source text: ID:nBw4DNJCja
Further company coverage: ALUR.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy